Twelve Leading Medical Centers Unite to Form Brain Tumor Research Collaborative

The UF Health-led ReMission Alliance Against Brain Tumors announced the names of twelve partner institutions from across the U.S. and Canada that are teaming up to develop novel treatments to vastly improve quality of life and long-term survival for patients fighting malignant brain tumors.

Internationally recognized neuro-oncologists and brain tumor investigators from the twelve partner institutions will form a one-of-a-kind research community for the advancement of brain tumor immunotherapy research and clinical trials.

Dr. Duane Mitchell and Dr. William A. Friedman, both from the Lillian S. Wells Department of Neurosurgery and directors of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, will lead the ReMission Alliance. “The group of institutions and researchers that form the ReMission Alliance Against Brain Tumors constitute, to my knowledge, the largest collective effort focused specifically on advancing safe and effective immunotherapy for children and adults with brain cancer,” said Mitchell. “We’re honored to work alongside these talented investigators and believe that this type of collaboration will create unprecedented momentum in our effort to improve the lives of those suffering from brain tumors.”

Learn more about Twelve Leading Medical Centers Unite to Form Brain Tumor Research Collaborative.